The World ADC Awards 2026 shortlist has been announced, recognizing the organizations, teams, technologies, and individuals driving innovation and advancing the field of antibody-drug conjugates.
Celebrating excellence across ADC discovery, development, manufacturing, and clinical advancement, the World ADC Awards honor those making a significant contribution to the continued evolution of this rapidly growing sector. This year’s shortlisted nominees represent a diverse cross-section of the ADC community, from emerging biotech innovators and pioneering platform technology developers to leading service providers and established industry leaders.
Best ADC Platform Technology
- AJICAP – Ajinomoto Co., Inc.
- ConjuAll – LigaChem Biosciences
- GlycoConnect – Lonza
- TMALIN – MediLink Therapeutics
- WuXi DARx – WuXi XDC
Best New ADC Drug Developer
- Aarvik Therapeutics Inc
- Callio Therapeutics
- Firefly Biotech
- Kivu Bioscience
- Valink Therapeutics
Most Promising ADC to Watch
- DS3939a – Daiichi Sankyo US
- Emiltatug ledadotin (Emi-Le) – Mersana Therapeutics/Servier
- JK06 – Salubris Biotherapeutics
- Mocertatug rezetecan (Mo-Rez) – GSK & Hansoh Bio
- Puxitatug samrotecan – AstraZeneca
- Sofetabart mipitecan – Eli Lilly and Company
- TUB-040 – Tubulis /Gilead Sciences
Best ADC Clinical Impact
- Belantamab mafodotin (Blenrep) – GSK
- Izalontamab brengitecan (Iza-bren) – Bristol Myers Squibb & SystImmune
- Pivekimab Sunirine (Decnupaz) – AbbVie
- HER3-DXd – Daiichi Sankyo & Merck Group
- IKS014 – Iksuda Therapeutics & Fosun Pharma
Best Up & Coming Solution Provider
- HUB Organoids
- LIDE Biotech
- LOTTE Biologics
- Sygnature Discovery
- Turbine
- Xcellon Biologics
Best CDMO
- Abzena
- AsymBio
- Axplora
- BSP Pharmaceuticals S.p.A.
- Lonza
- MilliporeSigma
- Piramal Pharma Ltd
- WuXi XDC
Best CRO
- Charles River Laboratories
- ChemExpress
- Crown Bioscience
- ICON plc
- NJ Bio, Inc.
- WuXi XDC
The World ADC Awards recognize the exceptional achievements that continue to shape the future of ADC development and bring transformative therapies closer to patients. The 2026 shortlist highlights the breadth of innovation taking place across the industry and the organizations leading the next generation of progress.
Congratulations to all those shortlisted. Your achievements continue to drive progress and shape the future of antibody-drug conjugates.
Winners will be announced live at the exclusive World ADC Awards Gala during World ADC San Diego this October.
To learn more about the awards and secure your place at the ceremony, visit: https://ter.li/nwy3abht
#WorldADC #WorldADCAwards #ADCCommunity #OncologyInnovation